Corrigendum to "Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events" [Int. J. Cardiol. Cardiovasc. Risk and Prev. 2023 Jun 25:18:200193]

Affiliations

• ¹ Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
• ² Department of Medical Information Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
• ³ Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
• ⁴ Department of Clinical Informatics, Jichi Medical University School of Medicine, Tochigi, Japan.
• ⁵ Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
• ⁶ Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan.
• ⁷ Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan.
• ⁸ Development Bank of Japan Inc., Tokyo, Japan.
• ⁹ Division of Cardiovascular Medicine, Tohoku University Hospital, Sendai, Japan.
• ¹⁰ Department of Medical Informatics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
• ¹¹ Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
• ¹² Open Innovation Center, National Cerebral and Cardiovascular Center, Osaka, Japan.
• ¹³ Precision Inc., Tokyo, Japan.
• ¹⁴ Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
• ¹⁵ Jichi Medical University School of Medicine, Tochigi, Japan.